Assuming spms is required, the following results were found.

  • What to know about secondary progressive multiple sclerosis (SPMS)

    with relapsing-remitting multiple sclerosis (RRMS) will eventually develop secondary progressive multiple sclerosis (SPMS). Because of advances in current treatment, fewer people go on to develop SPMS than before, and it takes longer to transition to...

    https://mschristian.org/index.php/blog/what-to-know-about-secondary-progressive-multiple-sclerosis-spms-1
  • #ECTRIMS2019 - Longer DMT Use and Female Sex Seen to Protect Against SPMS Conversion - Multiple Sclerosis News Today

    therapies (DMTs) for longer periods are less likely to transition to secondary progressive multiple sclerosis (SPMS) than others, according to a study based on the Italian MS registry. But patients whose disease starts after age 40, have a multifocal...

    https://mschristian.org/index.php/blog/ectrims2019-longer-dmt-use-and-female-sex-seen-to-protect-against-spms-conversion-multiple-sclerosis-news-today
  • Diagnosis and Symptoms of Secondary Progressive MS

    If you have secondary progressive multiple sclerosis (#SPMS), you most likely started out with the relapsing-remitting type (#RRMS). The shift to SPMS often happens slowly, and it can be hard to know for sure if your condition has changed. One way to...

    https://mschristian.org/index.php/blog/diagnosis-and-symptoms-of-secondary-progressive-ms
  • Fast Five Quiz: Secondary Progressive Multiple Sclerosis - Medscape

    are the hallmark of RRMS. Most patients with RRMS will eventually develop secondary progressive multiple sclerosis (SPMS); however, with the advent of newer disease-modifying therapies (DMTs) and due to variable efficacy of these therapies, the exact...

    https://mschristian.org/index.php/blog/fast-five-quiz-secondary-progressive-multiple-sclerosis-medscape
  • #ECTRIMS2019 - Mayzent's Benefits for MS Patients a 'Key Question,' Says EXPAND's Principal Investigator - Multiple Sclerosis News Today

    modulator, indicated for the treatment of people with relapsing-remitting MS (RRMS) and active secondary progressive MS (SPMS). Data from the EXPAND study (NCT01665144) was one of the key pieces of evidence for Mayzent’s approval. Involving 1,651...

    https://mschristian.org/index.php/blog/ectrims2019-mayzent-s-benefits-for-ms-patients-a-key-question-says-expand-s-principal-investigator-multiple-sclerosis-news-today
  • SPMS

    Secondary-Progressive (SPMS) Begins with an RMS classification that becomes consistently progressive and includes more frequent relapses with minor remission. Loss of physical and mental function are accumulated without recovery between attacks.

    https://mschristian.org/index.php/articles/80-q-and-a/ms-glossary/8019-spms
  • MS Patients Have Low Blood Levels of Infection-fighting Antibodies, Study Finds - Multiple Sclerosis News Today

    own, but were lower-than-normal across all MS subtypes and particularly low in people with secondary progressive disease (SPMS). “Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying...

    https://mschristian.org/index.php/blog/ms-patients-have-low-blood-levels-of-infection-fighting-antibodies-study-finds-multiple-sclerosis-news-today
  • SPMS and Diet: What Foods Can Help?

    coating protects the nerves and facilitates the propagation of nervous signals. Secondary progressive multiple sclerosis (SPMS) is the second stage of MS, which follows relapsing-remitting multiple sclerosis (RRMS). Appropriate exercise and healthy...

    https://mschristian.org/index.php/blog/spms-and-diet-what-foods-can-help
  • MS Therapies Among Limited Offerings Through AllianceRx Walgreens Prime

    of MS, including relapsing-remitting MS (RRMS), clinically isolated syndrome (CIS), and active secondary progressive MS (SPMS). Mayzent is manufactured by Novartis. #Mavenclad, manufactured by EMD Serono (known as Merck KGaA outside the U.S. and...

    https://mschristian.org/index.php/blog/ms-therapies-among-limited-offerings-through-alliancerx-walgreens-prime
  • Siponimod Delays Time to Wheelchair in Secondary Progressive MS - Neurology Times

    is a very large and compelling dataset from which to draw our understanding regarding the drug’s efficacy. It shows us that SPMS can be treated, particularly when there is evidence for active inflammation,” he said. Vermersch and colleagues concluded...

    https://mschristian.org/index.php/blog/siponimod-delays-time-to-wheelchair-in-secondary-progressive-ms-neurology-times
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    not use the water pistols,” she said. Data shows there is a lower risk of conversion to secondary progressive disease (SPMS) when newer therapies are used in patients who have not received prior treatment (treatment-naïve). Several studies have shown...

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Secondary Progressive

    (SPMS) Begins with an RMS classification that becomes consistently progressive and includes more frequent relapses with minor remission. Loss of physical and mental function are accumulated without recovery between attacks.

    https://mschristian.org/index.php/articles/80-q-and-a/ms-glossary/8023-secondary-progressive

Results 1 - 12 of 12
 
 

Follow Us on Twitter

Follow Us On Twitter - Image